Total Payments
$4,101
2024 Payments
$408.64
Companies
37
Transactions
195
Medicare Patients
12,587
Medicare Billing
$3.4M
Payment Breakdown by Category
Food & Beverage$3,806 (92.8%)
Other$250.00 (6.1%)
Education$27.78 (0.7%)
Gifts$18.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,806 | 190 | 92.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 2 | 6.1% |
| Education | $27.78 | 2 | 0.7% |
| Gift | $18.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $661.61 | 32 | $0 (2024) |
| Lilly USA, LLC | $518.57 | 26 | $0 (2024) |
| Shire North American Group Inc | $443.14 | 15 | $0 (2019) |
| IBSA Pharma Inc. | $331.52 | 21 | $0 (2022) |
| EISAI INC. | $328.97 | 6 | $0 (2022) |
| ABBVIE INC. | $249.67 | 16 | $0 (2024) |
| Radius Health, Inc. | $176.82 | 11 | $0 (2023) |
| Novo Nordisk Inc | $164.96 | 8 | $0 (2024) |
| Horizon Therapeutics plc | $155.66 | 8 | $0 (2022) |
| Amneal Pharmaceuticals LLC | $147.94 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $408.64 | 19 | ABBVIE INC. ($41.81) |
| 2023 | $270.70 | 13 | Amgen Inc. ($38.58) |
| 2022 | $591.90 | 18 | EISAI INC. ($146.64) |
| 2021 | $346.39 | 21 | IBSA Pharma Inc. ($78.28) |
| 2020 | $446.06 | 28 | Amgen Inc. ($118.90) |
| 2019 | $420.67 | 22 | Amgen Inc. ($182.63) |
| 2018 | $859.96 | 31 | Shire North American Group Inc ($353.13) |
| 2017 | $757.12 | 43 | Lilly USA, LLC ($191.23) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $32.87 | General |
| Category: Insulin Pump | ||||||
| 11/04/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/21/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/07/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: OSTEOPOROSIS | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.94 | General |
| 07/02/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/17/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: OSTEOPOROSIS | ||||||
| 04/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes Care | ||||||
| 03/25/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Bone Health | ||||||
| 01/08/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/30/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/19/2023 | Lilly USA, LLC | BAQSIMI (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Bone Health | ||||||
| 04/12/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes | ||||||
| 03/08/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Rare Disease | ||||||
| 03/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 3,070 | 69,225 | $2.4M | $1.3M |
| 2022 | 17 | 3,453 | 46,118 | $1.6M | $815,822 |
| 2021 | 18 | 3,199 | 35,933 | $1.2M | $608,929 |
| 2020 | 15 | 2,865 | 48,747 | $1.4M | $709,608 |
Total Patients
12,587
Total Services
200,023
Medicare Billing
$3.4M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 511 | 49,802 | $1.5M | $919,835 | 59.6% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 24 | 16,171 | $307,249 | $128,611 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 816 | 1,039 | $227,541 | $90,793 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 374 | 374 | $124,542 | $44,905 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 402 | 527 | $79,577 | $34,190 | 43.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 164 | 165 | $38,115 | $13,259 | 34.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 529 | 889 | $35,560 | $9,605 | 27.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 84 | 89 | $22,784 | $9,326 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 43 | $12,642 | $5,295 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $12,630 | $4,836 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $10,850 | $3,970 | 36.6% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 19 | 20 | $2,700 | $1,102 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,274 | $614.74 | 48.3% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 12 | 12 | $1,312 | $572.16 | 43.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 399 | 31,980 | $1.0M | $552,232 | 52.7% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 26 | 10,500 | $181,532 | $79,052 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 749 | 975 | $122,005 | $60,219 | 49.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 387 | 522 | $60,030 | $30,995 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 259 | 287 | $48,501 | $27,347 | 56.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 167 | 167 | $54,315 | $19,226 | 35.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 227 | 233 | $35,274 | $19,170 | 54.3% |
| 82306 | Vitamin d-3 level | Office | 2022 | 215 | 245 | $10,780 | $7,175 | 66.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 55 | 71 | $10,650 | $4,745 | 44.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 88 | 93 | $4,935 | $3,801 | 77.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 157 | 195 | $6,045 | $3,239 | 53.6% |
About Dr. Angela Boldo, M.D
Dr. Angela Boldo, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407054638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Boldo, M.D has received a total of $4,101 in payments from pharmaceutical and medical device companies, with $408.64 received in 2024. These payments were reported across 195 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,806).
As a Medicare-enrolled provider, Boldo has provided services to 12,587 Medicare beneficiaries, totaling 200,023 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine|Endocrinology, Diabetes & Metabolism
- Location Sarasota, FL
- Active Since 07/10/2007
- Last Updated 10/06/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1407054638
Products in Payments
- EVENITY (Biological) $410.50
- NATPARA (Drug) $369.87
- Lenvima (Drug) $328.97
- Tirosint (Drug) $316.10
- FORTEO (Drug) $299.54
- SYNTHROID (Drug) $173.09
- Tymlos (Biological) $152.28
- UNITHROID (Drug) $147.94
- TEPEZZA (Drug) $139.94
- STRENSIQ (Biological) $123.10
- Prolia (Biological) $111.61
- RETEVMO (Drug) $92.33
- Crysvita (Drug) $73.45
- JARDIANCE (Drug) $62.13
- NATPARA (PARATHYROID HORMONE) (Drug) $49.91
- TERIPARATIDE (Drug) $48.13
- RECORLEV (Drug) $45.19
- Ozempic (Drug) $44.81
- Victoza (Drug) $43.77
- INVOKANA (Drug) $43.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Sarasota
Dr. Mark Lupo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $429,711
Endocrinology, Diabetes & Metabolism $429,711
Jesus Perez, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $343,841
Endocrinology, Diabetes & Metabolism $343,841
Dr. Raymond De La Rosa, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $123,034
Endocrinology, Diabetes & Metabolism $123,034
Sonia Sharma, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,106
Endocrinology, Diabetes & Metabolism $6,106
Motaz Agabani, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,776
Endocrinology, Diabetes & Metabolism $5,776
Dr. Jose Antunes, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,974
Endocrinology, Diabetes & Metabolism $3,974